Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model

Pancreatic ductal adenocarcinoma (PDAC) is a particularly deadly disease. Chronic conditions, including obesity and type-2 diabetes are risk factors, thus making PDAC amenable to preventive strategies. We aimed to characterize the chemo-preventive effects of metformin, a widely used anti-diabetic dr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Chang, Hui-Hua, Moro, Aune, Chou, Caroline Ei Ne, Dawson, David W., French, Samuel, Schmidt, Andrea I., Sinnett-Smith, James, Hao, Fang, Hines, O. Joe, Eibl, Guido, Rozengurt, Enrique
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5897574/
https://ncbi.nlm.nih.gov/pubmed/29651002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-24337-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados